Multiple Sclerosis: Identifying Appropriate Treatment Options and What's on the Horizon
0290-0000-20-212-H01-P
This second module in a 3-part series will review developing, currently approved, and pipeline agents as well as indications for use of available treatment options in various MS stages.
1.50
Managing Multiple Sclerosis: Best Practices for Pharmacists Caring for Patients Including Special Populations
0290-0000-20-213-H01-P
This final module in a 3-part series includes essential counseling tips for pharmacists to ensure the safety of drug treatment regimens for patients with MS in these special populations.
1.50
Overview of COVID-19: Evolving Investigational Treatment Landscape and Emerging Data
0290-0000-20-208-H01-P
This activity will provide pharmacists with a quick introduction to COVID-19, with an emphasis on recent data that are emerging on therapeutic options for the management of patients with COVID-19, as well as a brief discussion of vaccine development.
1.00
A Pharmacist's Perspective in Hyperkalemia: Improving Clinical Outcomes With Safe and Effective Treatment Options
0290-0000-20-209-H01-P
This activity will review appropriate use, efficacy, and safety of treatments for hyperkalemia so pharmacists can ensure patients are receiving the appropriate therapy at the right time to provide optimal care.
0.75